Medicortex Finland Oyj

Medicortex Finland Oyj is a biotechnology company dedicated to developing diagnostics and treatments for acute neurodegenerative conditions, including traumatic brain injury (TBI) and concussion. The company is currently focusing on the development of a rapid test, based on a proprietary biomarker, for detection of TBI and concussion. Medicortex was founded by Dr. Adrian Harel in Turku, Finland, in 2014 and it operates as a public limited company. Dr. Harel has a track record in business management and leadership of early-stage biotechnology companies. ---- Kuvaus suomeksi: Medicortex Finland Oyj (http://www.medicortex.fi) on bioteknologian alan yritys, joka on keskittynyt parantamaan tapaturmaisten aivovammojen (TBI)...

Nfl,ice-hockey,rugbu,brain injury,head injury,concussion,diagnostics,tbi,sport,professional athletes,boxing,early detection,military,army,navy,soldier,combat,veteran,trauma,clinical trial,ptsd,and biotechnology

Medicortex finland oyj operates in the Biotechnology research industry.

Medicortex finland oyj's revenue is 11m - 100m

Medicortex finland oyj has 11 - 50 employees.